Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.6640
-0.1003 (-13.12%)
At close: Jul 31, 2026, 4:00 PM EDT
0.6821
+0.0181 (2.73%)
Pre-market: Aug 3, 2026, 5:53 AM EDT
CELZ Market Cap
CELZ has a market cap or net worth of $2.45 million as of August 3, 2026. Its market cap has decreased by -65.43% in one year.
Market Cap
2.45M
Enterprise Value
-3.38M
1-Year Change
-65.43%
Ranking
Category
Stock Price
$0.66
ChartMarket Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $2.45M, a decrease of -84.75%. That is a compound annual growth rate of -33.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.50M | -50.98% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
| Dec 3, 2021 | 16.10M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 2.88M |
| Artelo Biosciences | 2.68M |
| Clearmind Medicine | 2.51M |
| GRI Bio | 2.44M |
| Propanc Biopharma | 2.30M |
| Oragenics | 2.26M |
| Decoy Therapeutics | 2.19M |
| Azitra | 2.15M |